Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xin-Jia Cai has a total of 46 co-authors. Here are the top co-authors by number of shared publications:

  • Tie-Jun Li

    Department of Oral Pathology Peking University School and Hospital of Stomatology Beijing China

    29 shared publications
  • He-Yu Zhang

    Research Unit of Precision Pathologic Diagnosis in Tumors of the Oral and Maxillofacial Regions, Chinese Academy of Medical Sciences (2019RU034), Beijing, China

    24 shared publications
  • Chao-Ran Peng

    National Center of Stomatology and National Clinical Research Center for Oral Diseases and National Engineering Research Center of Oral Biomaterials and Digital Medical Devices

    23 shared publications
  • Jian-Yun Zhang

    Department of Oral Pathology, Peking University School and Hospital of Stomatology; National Center for Stomatology; National Clinical Research Center for Oral Diseases; National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing, 100081, China.

    23 shared publications
  • Xu Wang

    Department of Oral Medicine, Peking University School and Hospital of Stomatology

    22 shared publications
  • Xin Peng

    Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology

    21 shared publications

Latest Publications

  • Open Access

    Burden of Lip, Oral Cavity, and Pharyngeal Cancers in China: Estimated in 2022 and Projections to 2050

    by Chuanyang Ding, Li Gao, Yingying Cui, Gege Li, Chaoran Peng, Jianyun Zhang, Tiejun Li, Xinjia Cai

  • Open Access

    A computational pathology-based AI framework for predicting PD-L1 expression and prognosis in HNSCC

    by Yingying Cui, Chuanyang Ding, Long Li, Xinjia Cai

    Aim: To investigate interobserver variability in programmed cell death ligand 1 (PD-L1) combined positive score (CPS) assessment in head and neck squamous cell carcinoma (HNSCC) and to develop an artificial intelligence (AI)-based model for predicting PD-L1 expression and patient prognosis from hematoxylin and eosin (H&E)-stained slides. Methods: Fifty HNSCC specimens were independently evaluated for PD-L1 by pathologists with different experience levels. Agreement was assessed using Fleiss’ and Cohen’s κ. Whole-slide images were processed into tiles for deep learning using DenseNet121. Tile-level features were integrated via two machine learning pipelines to construct whole-slide prediction models. Multiple algorithms were tested, with performance evaluated in validation and testing cohorts. Prognostic value was analyzed using AI-derived risk stratification. Results: Interobserver agreement was low (Fleiss’ κ = 0.34), indicating substantial variability in CPS assessment. DenseNet121 achieved moderate predictive performance (AUC 0.641 in validation, 0.616 in testing). AI models significantly improved prediction accuracy, with logistic regression demonstrating the best performance (AUC 0.900 in validation, 0.851 in testing). AI-derived prediction scores effectively stratified overall survival, with multiple models showing significant prognostic discrimination (P < 0.05). Conclusions: AI models integrating deep learning and machine learning can accurately predict PD-L1 expression and stratify prognosis in HNSCC, outperforming tile-level deep learning alone.

  • Open Access

    Spatially resolved proteomics provides insights into the normal-dysplasia-tumor continuum in oral squamous cell carcinoma

    by Chaoran Peng, Xinjia Cai, Mingwei Huang, Yuankun Zhai, Jianyun Zhang, Tiejun Li

    Oral epithelial dysplasia is a recognized precursor lesion for oral squamous cell carcinoma (OSCC), yet the proteomic changes underlying the progression fr


  • Open Access

    Dissecting oral premalignant carcinogenesis: spatial omics mechanisms and nanomedicine-driven therapeutic innovation

    by Xinjia Cai, Yingying Cui, Chuanyang Ding, Yan Liu, Tiejun Li

    Oral potentially malignant disorder (OPMD) remains a critical clinical challenge for cancer interception. However, the progression of OPMD toward oral squamous cell carcinoma (OSCC) is driven by profound cellular heterogeneity and dynamic microenvironmental remodeling. The mechanisms underlying these processes are not yet fully understood. Recent advancements in single-cell and spatial omics have facilitated high-resolution decoding of the precancerous landscape, unveiling multistep epithelial cell plasticity, fibroblast heterogeneity with extracellular matrix remodeling, immune suppression, and inflammatory reprogramming, as well as coupled metabolic and redox alterations that govern malignant transformation. These insights into the cellular mechanisms have led to a paradigm shift in the understanding of OPMD, reclassifying it as an ecosystem-level disease rather than a purely epithelial pathology. Nanomedicine is a potent platform for translating mechanistic knowledge into precision diagnostics and interventions at the precancerous stage. Nanomaterial-based strategies have been demonstrated to facilitate several critical processes, including enabling early lesion visualization and risk stratification, immune microenvironment reactivation, anti-fibrotic and anti-inflammatory remodeling, and targeted regulation of metabolic and oxidative stress pathways. A mounting body of evidence from preclinical and clinical studies lends support to the notion that nanotechnology-assisted early detection, microenvironmental reprogramming, and the interception of malignant transformation across oral and other precancerous conditions are indeed feasible. This review integrates single-cell-resolved mechanisms of OPMD progression with state-of-the-art nanomedicine-based diagnostic and therapeutic strategies, highlighting convergent biological axes and translational opportunities. By integrating single-cell biology with nanotechnology-driven precision medicine, this work is expected to improve the development of a nanomedicine framework for early cancer detection and treatment and outline future directions and challenges toward clinical implementation.


  • Open Access

    Neurovascular coupling in bone regeneration: Mechanisms, advanced biomaterials and challenges

    by Yixin Ma, Nan Jiang, Liyuan Chen, He Zhang, Xinjia Cai, Karan Gulati, Danqing He, Zhigang Cai, Yan Liu

    Neurovascular interaction plays a central role in bone development, repair and regeneration. The coordinated activity between nerves and blood vessels not only ensures the delivery of oxygen, nutrients, and regulatory signals but also modulates skeletal cell behavior and immune responses. However, traditional therapeutic strategies, such as autografts and allografts, and synthetic scaffolds often fail to replicate the native neurovascular microenvironment, limiting their regenerative efficacy. This review outlines the regulatory mechanisms of neurovascular coupling in bone regeneration. Neural inputs, mediated through neurotrophic factors and neurotransmitters, regulate bone homeostasis by influencing the activity of osteoblasts and osteoclasts, while vascular networks supply essential oxygen and nutrients to support bone maintenance and repair. We then summarize recent advances in neurovascularized biomaterials, including neurotrophic factor‐loaded scaffolds, electroconductive composites, ion‐releasing ceramics, and endogenous electroactive materials, which enable synchronous neural, vascular, and osteogenic regeneration. In addition to functional materials, cell‐ and molecule‐based approaches further enhance neurovascularized bone repair. Together, these strategies represent a shift from passive fillers to multifunctional scaffolds capable of fulfilling complex repair processes. This review aims to bridge mechanistic understanding with material design, offering insights for next‐generation bone tissue engineering.


  • Open Access

    Computational pathology-based artificial intelligence platform for the identification of common oral potentially malignant disorders

    by Long Li, Jianyun Zhang, Xinjia Cai

    Oral potentially malignant disorders (OPMDs) refer to a group of significant precursor lesions for oral squamous cell carcinoma (OSCC). Early differential


  • Open Access

    Scientific Mapping and Knowledge Evolution of Global Areca Research

    by Chuanyang Ding, Yingying Cui, Tiejun Li, Xinjia Cai


  • [Progress in clinicopathological diagnosis of oral potentially malignant disorders].

    by Yingying Cui, Chuanyang Ding, Chaoran Peng, Jianyun Zhang, Xinjia Cai, Tiejun Li

    As the field of oral pathology has evolved, the nomenclature and classification of oral mucosal diseases with a remarkable risk of malignant transformation have undergone several modifications. In 2005, the World Health Organization (WHO) introduced the concept of oral potentially malignant disorders (OPMDs) as an alternative to the terms for oral precancerous lesions and precancerous conditions. In the consensus report by the WHO Collaborating Center for Oral Cancer of 2021, OPMD is defined as "any oral mucosal abnormality that is associated with a statistically increased risk of developing oral cancer."This definition encompasses a range of conditions, in-cluding oral leukoplakia, oral submucous fibrosis, proliferative verrucous leukoplakia, oral lichen planus, and other lesions. In light of the complex etiology, unclear pathogenesis, and carcinogenesis of OPMDs, early and precise diagnosis and treatment can contribute to the secondary prevention of oral cancer. For this reason, this review, which aims to provide a basis for the precise clinical diagnosis of OPMDs, was performed. Its aim was achieved by reviewing the historical evolution and research progress of the nomenclature, classification, and histopathological diagnostic criteria of OPMDs.